UNSPSC 51162107: Isoniazid/rifapentine

Definition: This classification is for a combination medication for TB treatment. The first component, ISONIAZID, has US FDA Unique Ingredient Identifier of V83O1VOZ8L. ISONIAZID is an International Non-Proprietary Name or INN. The second component, RIFAPENTINE, has US FDA Unique Ingredient Identifier of XJM390A33U. RIFAPENTINE is an International Non-Proprietary Name or INN.

UNSPSC 51162107 Isoniazid/rifapentine, a Commodity code, encompasses pharmaceutical products and services that state and local governments procure for emergency medical response, long-term care, mental health treatment, and forensic laboratory operations. Recent state and local opportunities under this code show minimal direct solicitation for the named pharmaceutical itself; instead, issuing bodies are acquiring broader pharmaceutical services—including drug distribution, dispensing, inventory management, vending and smart-locker systems, and reference materials for forensic analysis—where isoniazid/rifapentine may be one component among hundreds of line items. Collier County's single-source notice for Handtevy software (PUR20975, due September 24, 2026) involves EMS drug-dosage calculation and protocol integration but does not specify isoniazid/rifapentine. Dane County's RFP for pharmaceutical services to Badger Prairie Health Care Center (2026RFP061PR, due October 22, 2026) requires comprehensive drug distribution with no line-item specificity. The City of Tucson Fire Department's RFP for BLS/ALS pharmaceuticals and supplies (260217, due June 24, 2026) spans 251 line items with estimated annual quantities ranging from 1 to 120,000 units per item, reflecting the breadth of emergency medical inventory but not isolating isoniazid/rifapentine. West Texas Centers for Mental Health and Mental Retardation's RFP for prescription pharmacy services (RX1001, due August 21, 2026) covers 15,187 medication claims across psychiatric, neurological, and general therapeutic categories. Issuing bodies include county health departments, municipal fire departments, special-purpose districts, and public health centers across multiple states.

Geographic activity concentrates in Florida (Collier County, Seminole County, Pinellas County), Wisconsin (Dane County), Arizona (Tucson), Texas (West Texas Centers, Bernalillo County), and Oregon (Washington County). The code shows no recent market for isoniazid/rifapentine as an isolated line-item commodity; pharmaceutical procurement in state and local government is aggregated into comprehensive distribution or services contracts where this product, if used at all, appears as one of hundreds of stocked items under broader supplier relationships. Vendors pursuing this code should position themselves as pharmacy benefit managers, emergency medical supply distributors, or specialized pharmaceutical service providers rather than single-product manufacturers, and track RFPs from long-term care facilities, municipal fire departments, mental health service agencies, and forensic laboratories where drug inventory plays a role in operations.